Work

Comprehensive impact of PPARG mutations in familial partial lipodystrophy type 3: Diagnosis, therapeutic strategies

Year: 2025

Type: article

Abstract: This article reviews a paper in the World Journal of Diabetes . The study uncovers the link between PPARG gene mutations and metabolic disorders, such as insulin resistance, diabetes, and hypertriglyceridemia, and emphasizes the crucial role of genetic testing in precise diagnosis and personalized treatment. This article further points out that in-depth investigation into the clinical heterogeneity of PPARG mutations and their underlying mechanisms can contribute to optimizing management strategies. Meanwhile, the development of more effective targeted therapies and the conduct of extensive genomic research are of great significance for understanding familial partial lipodystrophy type 3 and related metabolic syndromes.

Source: World Journal of Diabetes

DOI: 10.4239/wjd.v16.i4.103675

Authors: Heng-Li Lai, Liu Yang

Institutions: Jiangxi Provincial People's Hospital, Nanchang Medical College

Language: English

Topic: Peroxisome Proliferator-Activated Receptors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: diamond

Funder: Amryt Pharma